Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-03-29

Clinical Trial Update: Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating lidocaine and tetracaine cream for postherpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine and Tetracaine Cream (lidocaine and tetracaine topical anesthetic)

Snippet

Sponsor: ZARS Pharma Inc. | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED